MDimune
Latest round
- Series B
Last raised
- Aug 2019
Total raised
- $13M
Investors
- 6
About MDimune
, operates as a smart drug delivery platform that focuses on developing anticancer therapeutics through BioDrone by addressing other diseases including osteoarthritis, chronic obstructive pulmonary disease, and neurodegenerative diseases. MDimune Inc. is a platform that has been developed by the designer of a drug delivery system designed for accurate administration of strong drugs to specified areas. The company's platform provides vesicles derived from immune or stem cells to biotechnology and pharmaceutical companies, facilitating the development of novel treatments that carry various medications to the intended region. This enables physicians to provide vesicle-based anticancer drugs to their patients.
Who invested in MDimune
6 investors across 2 rounds
See all investors in MDimune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MDimune
Who invested in MDimune?
MDimune has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MDimune raised?
MDimune has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did MDimune last raise money?
MDimune's most recent round on record is a Series B, in Aug 2019.
What does MDimune do?
, operates as a smart drug delivery platform that focuses on developing anticancer therapeutics through BioDrone by addressing other diseases including osteoarthritis, chronic obstructive pulmonary disease, and neurodegenerative diseases.
Where is MDimune headquartered?
MDimune is headquartered in South Korea.
Which VCs invest in companies like MDimune?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at MDimune's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like MDimune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.